Oxford Canabinoid Tech. Complete Phase 1 Clinical Trials on Programme 1 for CIPN Treatment

Video

25 Sep

Written By Rob Bennett

Rob Bennett https://www.oxcantech.com

Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial

A pharmaceutical approach to cannabinoids